JCXH-211
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for JCXH-211, covering 2025-07-23 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors [Phase 1]